Taiho Pharmaceutical Co., Ltd. ("Taiho") and Arcus Biosciences, Inc. (NYSE:RCUS, "Arcus") announced that Taiho exercised its option to develop and, if approved, commercialize casdatifan (International ...
MedPage Today on MSN
New Drug for Rare Neuroendocrine Tumors Shows Durable Activity
BERLIN -- Belzutifan (Welireg) induced durable responses in advanced pheochromocytoma or paraganglioma (PPGL) in a single-arm ...
Casdatifan activates hundreds of genes in response to low oxygen levels, and when oxygen levels return to normal, HIF-2a is turned off. In patients with ccRCC, HIF-2a remains activated in the presence ...
A certain biological pathway drives the inflammation seen in the skin disease psoriasis. A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin ...
A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all ...
A certain biological pathway, a set of linked reactions in the body, drives the inflammation seen in the skin disease psoriasis, a new study finds. The work could lead to improved therapies for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback